What Does Ypsomed AG Do?

Total employees1631
HeadquartersBurgdorf
Founded2003

Ypsomed AG is a leading independent developer and manufacturer of innovative injection and infusion systems for self-medication. The company, headquartered in Burgdorf, Switzerland, offers a comprehensive range of products and services for diabetes care (including its mylife Diabetescare brand offering insulin pumps, pen needles, and blood glucose monitoring systems) and other therapeutic areas such as growth hormones, infertility, and osteoporosis. Ypsomed is committed to making self-care simpler and safer for patients worldwide through user-friendly and high-quality medical technology.

Where Is Ypsomed AG's Headquarters?

Ypsomed AG officeYpsomed AG officeYpsomed AG officeYpsomed AG office
*Images sourced via web search. Rights belong to original owners

HQ Function

Global headquarters housing strategic management, corporate functions, research and development, and advanced manufacturing for key medical device product lines.

Notable Features:

State-of-the-art manufacturing facilities for medical devices, focus on precision engineering, automation, and adherence to stringent Swiss quality standards. The campus is designed to foster innovation and efficient production.

Work Culture:

Ypsomed fosters an innovative, quality-focused, and patient-centric work culture. Employees often describe an environment characterized by an entrepreneurial spirit, team orientation, and a passion for developing solutions that improve patients' lives.

HQ Significance:

The Burgdorf headquarters is the nerve center for Ypsomed's global operations, a hub for innovation in medical technology, and the primary site for manufacturing its core products, embodying the company's commitment to 'Swiss Made' quality.

Values Reflected in HQ: The headquarters reflects Ypsomed's core values of precision, quality, innovation, sustainability, and patient well-being, evident in its infrastructure, operational processes, and commitment to high-quality manufacturing.

Location:

Ypsomed AG supports a wide range of functions globally, including research and development, manufacturing of injection and infusion systems (primarily in Switzerland and Germany), and extensive sales, marketing, distribution, and customer support services. The company operates through a network of subsidiaries and distribution partners across Europe, North America, Asia, and other regions, ensuring the worldwide availability of its diabetes care products and other self-medication solutions to patients and healthcare providers.

Street Address:

Brunnmattstrasse 6

City:

Burgdorf

State/Province:

Bern

Country:

Switzerland

Where Else Does Ypsomed AG Operate Around the World?

Schwerin, Germany

Address: Ypsomed Produktion GmbH, Ludwig-Bölkow-Straße 10, 19061 Schwerin, Germany

Serves as a major production hub within the EU, ensuring efficient supply and leveraging local manufacturing expertise.

Solothurn, Switzerland

Address: Ypsomed AG, Högerli 2, 4500 Solothurn, Switzerland

Complements the Burgdorf headquarters in manufacturing and R&D, reinforcing Ypsomed's Swiss-based innovation and production capabilities.

West Chester, PA, USA

Address: Ypsomed Inc., 1393 Enterprise Drive, West Chester, PA 19380, USA

Drives market presence and provides dedicated services to customers and partners in the crucial North American healthcare market.

New Delhi, India

Address: Ypsomed India Pvt. Ltd., B-5/26, Safdarjung Enclave, New Delhi - 110029, India

Serves as a strategic base for penetrating and growing in the South Asian market, addressing the increasing demand for advanced medical devices.

Buying Intent Signals for Ypsomed AG

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Ypsomed AG? Meet the Executive Team

As of April 2025, Ypsomed AG' leadership includes:

Simon Michel - Chief Executive Officer (CEO) & Delegate of the Board of Directors
Jörg Müsse - Chief Financial Officer (CFO)
Ulrike Bauer - Chief Operating Officer (COO)
Nikolaos Sakkas - Chief Scientific Officer (CSO)
Sébastien Delarive - Chief Information Officer (CIO)

Who's Investing in Ypsomed AG?

Ypsomed AG has been backed by several prominent investors over the years, including:

Willy Michel (Anchor Shareholder, via direct holdings and Ypsomed Holding AG)
UBS Fund Management (Switzerland) AG
Credit Suisse Funds AG (now part of UBS Group)
Pictet Asset Management SA
Various institutional and private shareholders (as Ypsomed AG is publicly traded on the SIX Swiss Exchange)

What Leadership Changes Has Ypsomed AG Seen Recently?

Hire3
Exits1

Ypsomed has undertaken significant leadership updates over the past 12-18 months, appointing a new CFO, COO, and CSO to strengthen its executive team. These changes aim to steer the company through its next phase of growth and innovation in the medical technology sector.

Departures

Frank Mengis, Frank Mengis departed from his position as CFO.

New Appointments:

Ulrike Bauer, Ulrike Bauer was appointed as the new COO.
Jörg Müsse, Jörg Müsse was appointed as the new CFO.
Nikolaos Sakkas, Nikolaos Sakkas was appointed as the new CSO.

What Technology (Tech Stack) Is Used byYpsomed AG?

Discover the tools Ypsomed AG uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Ypsomed AG Email Formats and Examples

Ypsomed AG typically utilizes a standard corporate email format, most commonly `firstname.lastname@ypsomed.com`. This structure allows for easy and professional communication with employees across various departments and global locations.

firstname.lastname@ypsomed.com

Format

simon.michel@ypsomed.com

Example

90%

Success rate

What's the Latest News About Ypsomed AG?

Ypsomed Press Release • November 23, 2023

Ypsomed AG news: Ulrike Bauer to become new COO of Ypsomed

Ypsomed announced that Ulrike Bauer will take over the position of Chief Operations Officer (COO) and become a member of the Executive Management of Ypsomed, effective February 01, 2024. She brings extensive experience in the medical device industry....more

Ypsomed Press Release • November 8, 2023

Ypsomed AG news: Half-Year Results 2023/24: Strong growth continues

Ypsomed reported continued strong growth in the first half of the 2023/24 financial year, with significant increases in revenue, particularly driven by its autoinjector business and the mylife YpsoPump insulin pump....more

Ypsomed Press Release • October 2, 2023

Ypsomed AG news: Ypsomed sells pen needle and BGM businesses to MTD (Medical Technology and Devices)

Ypsomed announced the sale of its pen needle and blood glucose monitoring (BGM) businesses to Medical Technology and Devices (MTD). This strategic move allows Ypsomed to focus on its core growth areas: the development and manufacturing of its own injection and infusion systems....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Ypsomed AG, are just a search away.